SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 228 filers reported holding SAGE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $103 | -63.5% | 5 | -16.7% | 0.00% | – |
| Q2 2023 | $282 | +34.3% | 6 | +20.0% | 0.00% | – |
| Q1 2023 | $210 | +37.3% | 5 | +25.0% | 0.00% | – |
| Q4 2022 | $153 | -98.9% | 4 | -98.7% | 0.00% | -100.0% |
| Q3 2021 | $14,000 | -26.3% | 310 | -5.5% | 0.00% | 0.0% |
| Q2 2021 | $19,000 | -17.4% | 328 | +5.8% | 0.00% | -50.0% |
| Q1 2021 | $23,000 | -34.3% | 310 | -22.5% | 0.00% | -33.3% |
| Q4 2020 | $35,000 | +191.7% | 400 | +150.0% | 0.00% | +200.0% |
| Q4 2019 | $12,000 | – | 160 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |